ArticleJournal of clinical neurology (Seoul, Korea)2024

Treatment Outcome After Switching From Galcanezumab to Fremanezumab in Patients With Migraine.

Michelle Sojung Youn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.